Showing 1 - 6 results of 6 for search 'Lidiane Maria Boldrini Leite', query time: 0.04s Refine Results
  1. 1
    HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy

    HLA-G and CD152 Expression Levels Encourage the Use of Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells as an Alternative for Immunosuppressive Therapy by Bernardo Zoehler, Letícia Fracaro, Lidiane Maria Boldrini-Leite, José Samuel da Silva, Paul J. Travers, Paulo Roberto Slud Brofman, Maria da Graça Bicalho, Alexandra Cristina Senegaglia

    Published 2022-04-01
    Get full text
    Article
  2. 2
    Management of Airway Remodeling in a Mouse Model of Allergic Airways Inflammation Using Extracellular Vesicles from Human Bone Marrow-Derived Mesenchymal Stromal Cells

    Management of Airway Remodeling in a Mouse Model of Allergic Airways Inflammation Using Extracellular Vesicles from Human Bone Marrow-Derived Mesenchymal Stromal Cells by Felipe Yukio Ishikawa Fragoso, Pedro Vicente Michelotto, Addeli Bez Batti Angulski, Lidiane Maria Boldrini Leite, Alexandra Cristina Senegaglia, Márcia Olandoski, Alejandro Correa Dominguez, Paulo Roberto Slud Brofman

    Published 2022-03-01
    Get full text
    Article
  3. 3
    Effect of Hydroxyapatite Microspheres, Amoxicillin–Hydroxyapatite and Collagen–Hydroxyapatite Composites on Human Dental Pulp-Derived Mesenchymal Stem Cells

    Effect of Hydroxyapatite Microspheres, Amoxicillin–Hydroxyapatite and Collagen–Hydroxyapatite Composites on Human Dental Pulp-Derived Mesenchymal Stem Cells by Yasmine Mendes Pupo, Lidiane Maria Boldrini Leite, Alexandra Cristina Senegaglia, Liziane Antunes, Jessica Mendes Nadal, Eliane Leal de Lara, Rafael Eiji Saito, Sandra Regina Masetto Antunes, William Fernandes Lacerda, Paulo Vitor Farago

    Published 2021-12-01
    Get full text
    Article
  4. 4
    Quality Control Optimization for Minimizing Security Risks Associated with Mesenchymal Stromal Cell-Based Product Development

    Quality Control Optimization for Minimizing Security Risks Associated with Mesenchymal Stromal Cell-Based Product Development by Carmen Lúcia Kuniyoshi Rebelatto, Lidiane Maria Boldrini-Leite, Debora Regina Daga, Daniela Boscaro Marsaro, Isadora May Vaz, Valderez Ravaglio Jamur, Alessandra Melo de Aguiar, Thalita Bastida Vieira, Bianca Polak Furman, Cecília Oliveira Aguiar, Paulo Roberto Slud Brofman

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Treatment of Chronic Kidney Disease with Extracellular Vesicles from Mesenchymal Stem Cells and CD133<sup>+</sup> Expanded Cells: A Comparative Preclinical Analysis

    Treatment of Chronic Kidney Disease with Extracellular Vesicles from Mesenchymal Stem Cells and CD133<sup>+</sup> Expanded Cells: A Comparative Preclinical Analysis by Dayane Mayumi Miyasaki, Alexandra Cristina Senegaglia, Sérgio Adriane Bezerra de Moura, Amanda Leitolis, Luiz Guilherme Achcar Capriglione, Letícia Fracaro, Lidiane Maria Boldrini Leite, Paulo Henrique Utumi, Felipe Yukio Ishikawa Fragoso, Fernando Meyer, Alejandro Correa, Paulo Roberto Slud Brofman

    Published 2022-02-01
    Get full text
    Article
  6. 6
    Combined Use of Tocilizumab and Mesenchymal Stromal Cells in the Treatment of Severe Covid-19: Case Report

    Combined Use of Tocilizumab and Mesenchymal Stromal Cells in the Treatment of Severe Covid-19: Case Report by Alexandra Cristina Senegaglia, Carmen Lúcia Kuniyoshi Rebelatto, Claudio Luciano Franck, Juliana Souza Lima, Lidiane Maria Boldrini-Leite, Debora Regina Daga, Cleverson Alex Leitão, Patrícia Shigunov, Ana Paula de Azambuja, Elisa Bana, Daniela Boscaro Marsaro, Bruna Schaidt, Andressa Micosky, Valderez Ravaglio Jamur, Yara Schluga, Isadora May Vaz, Lisandro Lima Ribeiro, Alejandro Correa, e Paulo Roberto Slud Brofman

    Published 2021-06-01
    Get full text
    Article

Search Tools: